Back
Atara Biotherapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
37
ATRA
Atara Biotherapeutics
Last Price:
$11.27
Seasonality Move:
4.11%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.65 | Buy |
| 20-day SMA: | 11.71 | Sell |
| 50-day SMA: | 10.72 | Buy |
| 200-day SMA: | 11.74 | Sell |
| 8-day EMA: | 10.84 | Buy |
| 20-day EMA: | 11.22 | Buy |
| 50-day EMA: | 10.77 | Buy |
| 200-day EMA: | 14.19 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 51.71 | Buy |
| Chaikin Money Flow: | 138596 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.63 - 12.55) | Sell |
| Bollinger Bands (100): | (7.42 - 11.18) | Buy |
Atara Biotherapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 11.40 while ATRA 8-day simple moving average is 10.65, which is a Buy signal.
-
The stock price of ATRA is 11.40 while Atara Biotherapeutics 20-day SMA is 11.71, which makes it a Sell.
-
Atara Biotherapeutics 50-day simple moving average is 10.72 while ATRA share price is 11.40, making it a Buy technically.
-
ATRA stock price is 11.40 and Atara Biotherapeutics 200-day simple moving average is 11.74, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
37
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a SellThe current Atara Biotherapeutics [ATRA] share price is $11.40. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
65.7M
Price in USD:
11.40
Share Volume:
151.8K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Sell
37
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 11.40 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 11.40 while ATRA 8-day exponential moving average is 10.84, which is a Buy signal.
-
The stock price of ATRA is 11.40 while Atara Biotherapeutics 20-day EMA is 11.22, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 10.77 while ATRA share price is 11.40, making it a Buy technically.
-
ATRA stock price is 11.40 and Atara Biotherapeutics 200-day simple moving average is 14.19, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $61.17 per share, and a decrease next year of $10.45 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Atara Biotherapeutics is a Sell
-
Atara Biotherapeutics Relative Strength Index (RSI) is 51.71, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (10.63 - 12.55), which suggest Atara Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.42 - 11.18), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.